These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9276014)

  • 41. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
    Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
    J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.
    Kulagowski JJ; Broughton HB; Curtis NR; Mawer IM; Ridgill MP; Baker R; Emms F; Freedman SB; Marwood R; Patel S; Patel S; Ragan CI; Leeson PD
    J Med Chem; 1996 May; 39(10):1941-2. PubMed ID: 8642550
    [No Abstract]   [Full Text] [Related]  

  • 44. Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists.
    Glase SA; Akunne HC; Georgic LM; Heffner TG; MacKenzie RG; Manley PJ; Pugsley TA; Wise LD
    J Med Chem; 1997 Jun; 40(12):1771-2. PubMed ID: 9191952
    [No Abstract]   [Full Text] [Related]  

  • 45. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Langenegger D; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1999 Oct; 128(3):613-20. PubMed ID: 10516640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryptic initiation at the human D4 receptor reveals a functional role for the amino terminus.
    Schoots O; Sanyal S; Guan HC; Jovanovic V; Van Tol HH
    Biochemistry; 1996 Mar; 35(11):3614-8. PubMed ID: 8639513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.
    Heuillet E; Petitet F; Mignani S; Malleron JL; Lavayre J; Néliat G; Doble A; Blanchard JC
    Eur J Pharmacol; 1996 Oct; 314(1-2):229-33. PubMed ID: 8957240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-Phenyl-4-(aminomethyl)imidazoles as potential antipsychotic agents. Synthesis and dopamine D2 receptor binding.
    Thurkauf A; Hutchison A; Peterson J; Cornfield L; Meade R; Huston K; Harris K; Ross PC; Gerber K; Ramabhadran TV
    J Med Chem; 1995 Jun; 38(12):2251-5. PubMed ID: 7783157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.
    Rowley M; Broughton HB; Collins I; Baker R; Emms F; Marwood R; Patel S; Patel S; Ragan CI; Freedman SB; Leeson PD
    J Med Chem; 1996 May; 39(10):1943-5. PubMed ID: 8642551
    [No Abstract]   [Full Text] [Related]  

  • 51. 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.
    Bergauer M; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1937-40. PubMed ID: 12113813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
    Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.
    Agai-Csongor E; Domány G; Nógrádi K; Galambos J; Vágó I; Keserű GM; Greiner I; Laszlovszky I; Gere A; Schmidt E; Kiss B; Vastag M; Tihanyi K; Sághy K; Laszy J; Gyertyán I; Zájer-Balázs M; Gémesi L; Kapás M; Szombathelyi Z
    Bioorg Med Chem Lett; 2012 May; 22(10):3437-40. PubMed ID: 22537450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships.
    Glase SA; Akunne HC; Heffner TG; Jaen JC; MacKenzie RG; Meltzer LT; Pugsley TA; Smith SJ; Wise LD
    J Med Chem; 1996 Aug; 39(16):3179-87. PubMed ID: 8759640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.
    Zhao H; Thurkauf A; Braun J; Brodbeck R; Kieltyka A
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2119-22. PubMed ID: 10999484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor.
    Rowley M; Collins I; Broughton HB; Davey WB; Baker R; Emms F; Marwood R; Patel S; Patel S; Ragan CI; Freedman SB; Ball R; Leeson PD
    J Med Chem; 1997 Jul; 40(15):2374-85. PubMed ID: 9240352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1969-72. PubMed ID: 10450964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range.
    Abdel-Fattah MA; Lehmann J; Abadi AH
    Chem Biodivers; 2013 Dec; 10(12):2247-66. PubMed ID: 24327445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
    Thurkauf A; Yuan J; Chen X; He XS; Wasley JW; Hutchison A; Woodruff KH; Meade R; Hoffman DC; Donovan H; Jones-Hertzog DK
    J Med Chem; 1997 Jan; 40(1):1-3. PubMed ID: 9016321
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of [3H]-clozapine as a ligand of the dopamine D4 receptor subtype in peripheral tissues.
    Ricci A; Bronzetti E; Rossodivita I; Amenta F
    J Auton Pharmacol; 1997 Aug; 17(4):261-7. PubMed ID: 9373785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.